<div id="readability-page-1"><p>Genpact Limited (NYSE:G - Get Free Report)'s stock price reached a new 52-week low on Wednesday after Mizuho lowered their price target on the stock from $51.00 to $49.00. Mizuho currently has a neutral rating on the stock. Genpact traded as low as $37.36 and last traded at $37.4280, with a volume of 3144129 shares. The stock had previously closed at $39.14.</p><ul><li>GE Vernova Rallies on the AI Grid Supercycle: Turbines, Transformers, and Cash Returns</li></ul><p>G has been the subject of several other reports. Citigroup raised Genpact to a &#34;hold&#34; rating in a research report on Thursday, October 23rd. Wall Street Zen upgraded Genpact from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, January 10th. Needham &amp; Company LLC dropped their price target on Genpact from $53.00 to $50.00 and set a &#34;buy&#34; rating on the stock in a research note on Friday, February 6th. Weiss Ratings  reaffirmed a &#34;hold (c+)&#34; rating on shares of Genpact in a research report on Friday, December 26th. Finally, Susquehanna  set a $42.00 price objective on shares of Genpact in a research note on Friday, February 6th. One research analyst  has rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and an average price target of $47.29.</p><p><b>View Our Latest Stock Analysis on Genpact</b></p><h2>Insider Transactions at Genpact</h2><ul><li>Insiders Buy 3 High-Risk Stocks—Here’s What’s Driving the Moves</li></ul><p>In other news, SVP Riju Vashisht sold 16,016 shares of the stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total transaction of $747,146.40. Following the transaction, the senior vice president directly owned 95,521 shares in the company, valued at approximately $4,456,054.65. This represents a 14.36% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, SVP Sameer Dewan sold 15,088 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total value of $703,855.20. Following the completion of the sale, the senior vice president owned 37,749 shares of the company's stock, valued at $1,760,990.85. The trade was a 28.56% decrease in their position. The SEC filing for this sale provides additional information. 3.07% of the stock is currently owned by corporate insiders. </p><h2>Institutional Investors Weigh In On Genpact</h2><p>Large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its stake in shares of  Genpact by 2.6% during the fourth quarter. Geode Capital Management LLC now owns 4,330,116 shares of the business services provider's stock valued at $210,391,000 after acquiring an additional 107,870 shares during the last quarter.  Dimensional Fund Advisors LP raised its holdings in shares of  Genpact by 8.7% during the third quarter. Dimensional Fund Advisors LP now owns 3,978,210 shares of the business services provider's stock valued at $166,651,000 after acquiring an additional 319,861 shares in the last quarter.  JPMorgan Chase &amp; Co. lifted its stake in  Genpact by 17.1% in the third quarter. JPMorgan Chase &amp; Co. now owns 3,762,407 shares of the business services provider's stock worth $157,609,000 after acquiring an additional 549,117 shares during the period.  Franklin Resources Inc. lifted its stake in  Genpact by 3.8% in the fourth quarter. Franklin Resources Inc. now owns 3,508,847 shares of the business services provider's stock worth $164,144,000 after acquiring an additional 129,664 shares during the period.  Finally, AQR Capital Management LLC increased its position in  Genpact by 170.4% during the 3rd quarter. AQR Capital Management LLC now owns 3,443,472 shares of the business services provider's stock valued at $144,247,000 after purchasing an additional 2,170,145 shares during the period. Institutional investors own  96.03% of the company's stock. </p><h2>Genpact Stock Down 4.4%</h2><ul><li>3 High-Risk Stocks That Soared in 2025 But Can Still Fly Higher</li></ul><p>The company's fifty day simple moving average is $45.72 and its 200 day simple moving average is $43.64. The company has a current ratio of 1.66, a quick ratio of 1.51 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $6.45 billion, a P/E ratio of 11.93, a price-to-earnings-growth ratio of 1.15 and a beta of 0.74. </p><p>Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 5th. The business services provider reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.04. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The company's revenue for the quarter was up 5.6% compared to the same quarter last year. Genpact has set its FY 2026 guidance at 4.010-4.010 EPS and its Q1 2026 guidance at 0.920-0.930 EPS.  Research analysts expect that  Genpact Limited will post 3.21 EPS for the current year. </p><h2>Genpact Increases Dividend</h2><p>The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th will be given a $0.1875 dividend. The ex-dividend date of this dividend is Monday, March 16th. This represents a $0.75 annualized dividend and a dividend yield of 2.0%. This is an increase from Genpact's previous quarterly dividend of $0.17. Genpact's dividend payout ratio  is currently 23.96%. </p><h2>Genpact Company Profile</h2> (Get Free Report)<p>Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.  </p><p>Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.  </p><p>Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Genpact</li><li>Your Bank Account Is No Longer Safe</li><li>Nvidia CEO Issues Bold Tesla Call</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>Buy this Gold Stock Before May 2026</li><li>What a Former CIA Agent Knows About the Coming Collapse</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Genpact Right Now?</h2><p>Before you consider Genpact, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.</p><p>While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Genpact (NYSE:G) reached a new 52-week low of $37.36 after Mizuho downgraded its price target from $51 to $49, maintaining a neutral rating. The stock closed at $37.4280 with a trading volume of over 3 million shares. Analysts have mixed ratings, with one buy and seven hold ratings, and a consensus target of $47.29. Institutional investors hold 96.03% of the stock, and recent insider sales have been reported. Genpact's market cap is $6.45 billion, with a P/E ratio of 11.93 and a net margin of 10.88%.</p>

Genpact (NYSE:G) Reaches New 52-Week Low Following Analyst Downgrade